Literature DB >> 22992228

Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?

Pier Paolo Piccaluga, Stefania Paolini, Maria Rosaria Sapienza, Stefano A Pileri.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22992228     DOI： 10.1586/ehm.12.33

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN： 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  7 in total

1.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

2.  In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Authors:  Fanny Angelot-Delettre; Anne Roggy; Arthur E Frankel; Baptiste Lamarthee; Estelle Seilles; Sabeha Biichle; Bernard Royer; Eric Deconinck; Eric K Rowinsky; Christopher Brooks; Valerie Bardet; Blandine Benet; Hind Bennani; Zehaira Benseddik; Agathe Debliquis; Daniel Lusina; Mikael Roussel; Françoise Solly; Michel Ticchioni; Philippe Saas; Francine Garnache-Ottou
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

3.  Reply to "A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm" and to "A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement" dendritic cell leukemia.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Fabio Facchetti
Journal:  Haematologica       Date:  2013-03       Impact factor: 9.941

4.  Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

Authors:  Kamel Laribi; Alix Baugier de Materre; Mohamad Sobh; Lorenzo Cerroni; Caterina Giovanna Valentini; Tomohiro Aoki; Ritsuro Suzuki; Kengo Takeuchi; Arthur E Frankel; Carlo Cota; David Ghez; Ronan Le Calloch; Livio Pagano; Tony Petrella
Journal:  Blood Adv       Date:  2020-10-13

5.  Blastic plasmacytoid dendritic cell neoplasm following acquired erythropoietic protoporphyria.

Authors:  John R Krause; Laura Baugh; Alicia Swink; Micah Burch
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-10

6.  Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: A case report.

Authors:  N A Gao; Xue-Xia Wang; Jian-Rong Sun; Wen-Zheng Yu; Nong-Jian Guo
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

7.  Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Laure Philippe; Adam Ceroi; Elodie Bôle-Richard; Alizée Jenvrin; Sabeha Biichle; Sophie Perrin; Samuel Limat; Francis Bonnefoy; Eric Deconinck; Philippe Saas; Francine Garnache-Ottou; Fanny Angelot-Delettre
Journal:  Haematologica       Date:  2017-08-10       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.